Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP225889.RAYjV6K21vBPSlJLClAm6xSI9hJEzBDstLkRXcy9HHNmQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP225889.RAYjV6K21vBPSlJLClAm6xSI9hJEzBDstLkRXcy9HHNmQ130_assertion type Assertion NP225889.RAYjV6K21vBPSlJLClAm6xSI9hJEzBDstLkRXcy9HHNmQ130_head.
- NP225889.RAYjV6K21vBPSlJLClAm6xSI9hJEzBDstLkRXcy9HHNmQ130_assertion description "[Somatic mutation in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene is associated with the sensitivity of non-smal cell lung cancer (NSCLC) to TK inhibitor Gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225889.RAYjV6K21vBPSlJLClAm6xSI9hJEzBDstLkRXcy9HHNmQ130_provenance.
- NP225889.RAYjV6K21vBPSlJLClAm6xSI9hJEzBDstLkRXcy9HHNmQ130_assertion evidence source_evidence_literature NP225889.RAYjV6K21vBPSlJLClAm6xSI9hJEzBDstLkRXcy9HHNmQ130_provenance.
- NP225889.RAYjV6K21vBPSlJLClAm6xSI9hJEzBDstLkRXcy9HHNmQ130_assertion SIO_000772 17548322 NP225889.RAYjV6K21vBPSlJLClAm6xSI9hJEzBDstLkRXcy9HHNmQ130_provenance.
- NP225889.RAYjV6K21vBPSlJLClAm6xSI9hJEzBDstLkRXcy9HHNmQ130_assertion wasDerivedFrom lhgdn-20090331 NP225889.RAYjV6K21vBPSlJLClAm6xSI9hJEzBDstLkRXcy9HHNmQ130_provenance.
- NP225889.RAYjV6K21vBPSlJLClAm6xSI9hJEzBDstLkRXcy9HHNmQ130_assertion wasGeneratedBy ECO_0000203 NP225889.RAYjV6K21vBPSlJLClAm6xSI9hJEzBDstLkRXcy9HHNmQ130_provenance.